Global and China Risperidone Market Insights, Forecast to 2027

Publisher Name :
Date: 28-Sep-2021
No. of pages: 157
Inquire Before Buying

Risperidone market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Risperidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Risperidone market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Oral

- Injectable

Segment by Application

- Schizophrenia

- Bipolar Disorder

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Janssen Pharmaceutica

- Teva

- Sun Pharmaceutical

- Aurobindo

- Cipla

- Invent Farma Group

- Medichem

- Interquim

- IPCA

- RPG

- Sharon

- Torrent Pharmaceuticals

- Temad

- Wuxi Jida

- Changzhou Siyao Pharmaceuticals

- Ningbo Team Pharm

- Zhejiang Huahai Pharmaceutical

- TIPR

- Qilu Pharmaceutical

Global and China Risperidone Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Risperidone Product Introduction
1.2 Market by Type
1.2.1 Global Risperidone Market Size Growth Rate by Type
1.2.2 Oral
1.2.3 Injectable
1.3 Market by Application
1.3.1 Global Risperidone Market Size Growth Rate by Application
1.3.2 Schizophrenia
1.3.3 Bipolar Disorder
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Risperidone Market Size, Estimates and Forecasts
2.1.1 Global Risperidone Revenue 2016-2027
2.1.2 Global Risperidone Sales 2016-2027
2.2 Global Risperidone, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Risperidone Historical Market Size by Region (2016-2021)
2.3.1 Global Risperidone Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Risperidone Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Risperidone Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Risperidone Sales Forecast by Region (2022-2027)
2.4.2 Global Risperidone Revenue Forecast by Region (2022-2027)
3 Global Risperidone Competitor Landscape by Players
3.1 Global Top Risperidone Manufacturers by Sales
3.1.1 Global Risperidone Sales by Manufacturer (2016-2021)
3.1.2 Global Risperidone Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Risperidone Manufacturers by Revenue
3.2.1 Key Risperidone Manufacturers Covered: Ranking by Revenue
3.2.2 Global Risperidone Revenue by Manufacturers (2016-2021)
3.2.3 Global Risperidone Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Risperidone Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Risperidone Revenue in 2020
3.2.6 Global Risperidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Risperidone Price by Manufacturers
3.4 Global Risperidone Manufacturing Base Distribution, Product Types
3.4.1 Risperidone Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Risperidone Product Type
3.4.3 Date of International Manufacturers Enter into Risperidone Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Risperidone Market Size by Type (2016-2021)
4.1.1 Global Risperidone Sales by Type (2016-2021)
4.1.2 Global Risperidone Revenue by Type (2016-2021)
4.1.3 Risperidone Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Risperidone Market Size Forecast by Type (2022-2027)
4.2.1 Global Risperidone Sales Forecast by Type (2022-2027)
4.2.2 Global Risperidone Revenue Forecast by Type (2022-2027)
4.2.3 Risperidone Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Risperidone Market Size by Application (2016-2021)
5.1.1 Global Risperidone Sales by Application (2016-2021)
5.1.2 Global Risperidone Revenue by Application (2016-2021)
5.1.3 Risperidone Price by Application (2016-2021)
5.2 Risperidone Market Size Forecast by Application (2022-2027)
5.2.1 Global Risperidone Sales Forecast by Application (2022-2027)
5.2.2 Global Risperidone Revenue Forecast by Application (2022-2027)
5.2.3 Global Risperidone Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Risperidone Market Size YoY Growth 2016-2027
6.1.1 China Risperidone Sales YoY Growth 2016-2027
6.1.2 China Risperidone Revenue YoY Growth 2016-2027
6.1.3 China Risperidone Market Share in Global Market 2016-2027
6.2 China Risperidone Market Size by Players (International and Local Players)
6.2.1 China Top Risperidone Players by Sales (2016-2021)
6.2.2 China Top Risperidone Players by Revenue (2016-2021)
6.3 China Risperidone Historic Market Review by Type (2016-2021)
6.3.1 China Risperidone Sales Market Share by Type (2016-2021)
6.3.2 China Risperidone Revenue Market Share by Type (2016-2021)
6.3.3 China Risperidone Price by Type (2016-2021)
6.4 China Risperidone Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Risperidone Sales Forecast by Type (2022-2027)
6.4.2 China Risperidone Revenue Forecast by Type (2022-2027)
6.4.3 China Risperidone Price Forecast by Type (2022-2027)
6.5 China Risperidone Historic Market Review by Application (2016-2021)
6.5.1 China Risperidone Sales Market Share by Application (2016-2021)
6.5.2 China Risperidone Revenue Market Share by Application (2016-2021)
6.5.3 China Risperidone Price by Application (2016-2021)
6.6 China Risperidone Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Risperidone Sales Forecast by Application (2022-2027)
6.6.2 China Risperidone Revenue Forecast by Application (2022-2027)
6.6.3 China Risperidone Price Forecast by Application (2022-2027)
7 North America
7.1 North America Risperidone Market Size YoY Growth 2016-2027
7.2 North America Risperidone Market Facts & Figures by Country
7.2.1 North America Risperidone Sales by Country (2016-2021)
7.2.2 North America Risperidone Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Risperidone Market Size YoY Growth 2016-2027
8.2 Asia Pacific Risperidone Market Facts & Figures by Region
8.2.1 Asia Pacific Risperidone Sales by Region (2016-2021)
8.2.2 Asia Pacific Risperidone Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Risperidone Market Size YoY Growth 2016-2027
9.2 Europe Risperidone Market Facts & Figures by Country
9.2.1 Europe Risperidone Sales by Country (2016-2021)
9.2.2 Europe Risperidone Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Risperidone Market Size YoY Growth 2016-2027
10.2 Latin America Risperidone Market Facts & Figures by Country
10.2.1 Latin America Risperidone Sales by Country (2016-2021)
10.2.2 Latin America Risperidone Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Risperidone Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Risperidone Market Facts & Figures by Country
11.2.1 Middle East and Africa Risperidone Sales by Country (2016-2021)
11.2.2 Middle East and Africa Risperidone Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Janssen Pharmaceutica
12.1.1 Janssen Pharmaceutica Corporation Information
12.1.2 Janssen Pharmaceutica Description and Business Overview
12.1.3 Janssen Pharmaceutica Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Janssen Pharmaceutica Risperidone Products Offered
12.1.5 Janssen Pharmaceutica Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Description and Business Overview
12.2.3 Teva Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Teva Risperidone Products Offered
12.2.5 Teva Recent Development
12.3 Sun Pharmaceutical
12.3.1 Sun Pharmaceutical Corporation Information
12.3.2 Sun Pharmaceutical Description and Business Overview
12.3.3 Sun Pharmaceutical Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sun Pharmaceutical Risperidone Products Offered
12.3.5 Sun Pharmaceutical Recent Development
12.4 Aurobindo
12.4.1 Aurobindo Corporation Information
12.4.2 Aurobindo Description and Business Overview
12.4.3 Aurobindo Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Aurobindo Risperidone Products Offered
12.4.5 Aurobindo Recent Development
12.5 Cipla
12.5.1 Cipla Corporation Information
12.5.2 Cipla Description and Business Overview
12.5.3 Cipla Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Cipla Risperidone Products Offered
12.5.5 Cipla Recent Development
12.6 Invent Farma Group
12.6.1 Invent Farma Group Corporation Information
12.6.2 Invent Farma Group Description and Business Overview
12.6.3 Invent Farma Group Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Invent Farma Group Risperidone Products Offered
12.6.5 Invent Farma Group Recent Development
12.7 Medichem
12.7.1 Medichem Corporation Information
12.7.2 Medichem Description and Business Overview
12.7.3 Medichem Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Medichem Risperidone Products Offered
12.7.5 Medichem Recent Development
12.8 Interquim
12.8.1 Interquim Corporation Information
12.8.2 Interquim Description and Business Overview
12.8.3 Interquim Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Interquim Risperidone Products Offered
12.8.5 Interquim Recent Development
12.9 IPCA
12.9.1 IPCA Corporation Information
12.9.2 IPCA Description and Business Overview
12.9.3 IPCA Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.9.4 IPCA Risperidone Products Offered
12.9.5 IPCA Recent Development
12.10 RPG
12.10.1 RPG Corporation Information
12.10.2 RPG Description and Business Overview
12.10.3 RPG Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.10.4 RPG Risperidone Products Offered
12.10.5 RPG Recent Development
12.11 Janssen Pharmaceutica
12.11.1 Janssen Pharmaceutica Corporation Information
12.11.2 Janssen Pharmaceutica Description and Business Overview
12.11.3 Janssen Pharmaceutica Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Janssen Pharmaceutica Risperidone Products Offered
12.11.5 Janssen Pharmaceutica Recent Development
12.12 Torrent Pharmaceuticals
12.12.1 Torrent Pharmaceuticals Corporation Information
12.12.2 Torrent Pharmaceuticals Description and Business Overview
12.12.3 Torrent Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Torrent Pharmaceuticals Products Offered
12.12.5 Torrent Pharmaceuticals Recent Development
12.13 Temad
12.13.1 Temad Corporation Information
12.13.2 Temad Description and Business Overview
12.13.3 Temad Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Temad Products Offered
12.13.5 Temad Recent Development
12.14 Wuxi Jida
12.14.1 Wuxi Jida Corporation Information
12.14.2 Wuxi Jida Description and Business Overview
12.14.3 Wuxi Jida Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Wuxi Jida Products Offered
12.14.5 Wuxi Jida Recent Development
12.15 Changzhou Siyao Pharmaceuticals
12.15.1 Changzhou Siyao Pharmaceuticals Corporation Information
12.15.2 Changzhou Siyao Pharmaceuticals Description and Business Overview
12.15.3 Changzhou Siyao Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Changzhou Siyao Pharmaceuticals Products Offered
12.15.5 Changzhou Siyao Pharmaceuticals Recent Development
12.16 Ningbo Team Pharm
12.16.1 Ningbo Team Pharm Corporation Information
12.16.2 Ningbo Team Pharm Description and Business Overview
12.16.3 Ningbo Team Pharm Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Ningbo Team Pharm Products Offered
12.16.5 Ningbo Team Pharm Recent Development
12.17 Zhejiang Huahai Pharmaceutical
12.17.1 Zhejiang Huahai Pharmaceutical Corporation Information
12.17.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
12.17.3 Zhejiang Huahai Pharmaceutical Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Zhejiang Huahai Pharmaceutical Products Offered
12.17.5 Zhejiang Huahai Pharmaceutical Recent Development
12.18 TIPR
12.18.1 TIPR Corporation Information
12.18.2 TIPR Description and Business Overview
12.18.3 TIPR Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.18.4 TIPR Products Offered
12.18.5 TIPR Recent Development
12.19 Qilu Pharmaceutical
12.19.1 Qilu Pharmaceutical Corporation Information
12.19.2 Qilu Pharmaceutical Description and Business Overview
12.19.3 Qilu Pharmaceutical Risperidone Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Qilu Pharmaceutical Products Offered
12.19.5 Qilu Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Risperidone Industry Trends
13.2 Risperidone Market Drivers
13.3 Risperidone Market Challenges
13.4 Risperidone Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Risperidone Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Risperidone Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Injectable
Table 4. Global Risperidone Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 5. Global Risperidone Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Risperidone Sales by Regions (2016-2021) & (K Pcs)
Table 7. Global Risperidone Sales Market Share by Regions (2016-2021)
Table 8. Global Risperidone Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Risperidone Sales Forecast by Region (2022-2027) & (K Pcs)
Table 10. Global Risperidone Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Risperidone Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Risperidone Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Risperidone Sales by Manufacturers (2016-2021) (K Pcs)
Table 14. Global Risperidone Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Risperidone Manufacturers by Revenue (US$ Million) in 2020
Table 16. Risperidone Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Risperidone Revenue Share by Manufacturers (2016-2021)
Table 18. Global Risperidone Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Risperidone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Risperidone as of 2020)
Table 20. Key Manufacturers Risperidone Price (2016-2021) (USD/Pcs)
Table 21. Risperidone Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Risperidone Product Type
Table 23. Date of International Manufacturers Enter into Risperidone Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Risperidone Sales by Type (2016-2021) (K Pcs)
Table 26. Global Risperidone Sales Share by Type (2016-2021)
Table 27. Global Risperidone Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Risperidone Revenue Share by Type (2016-2021)
Table 29. Risperidone Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 30. Global Risperidone Sales Forecast by Type (2022-2027) & (K Pcs)
Table 31. Global Risperidone Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Risperidone Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Risperidone Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Risperidone Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 35. Global Risperidone Sales by Application (2016-2021) (K Pcs)
Table 36. Global Risperidone Sales Share by Application (2016-2021)
Table 37. Global Risperidone Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Risperidone Revenue Share by Application (2016-2021)
Table 39. Risperidone Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 40. Global Risperidone Sales Forecast by Application (2022-2027) & (K Pcs)
Table 41. Global Risperidone Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Risperidone Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Risperidone Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Risperidone Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 45. China Risperidone Sales (K Pcs) of Key Companies (2016-2021)
Table 46. China Risperidone Sales Share by Company (2016-2021)
Table 47. China Risperidone Revenue (US$ Million) by Company (2016-2021)
Table 48. China Risperidone Revenue Share by Company (2016-2021)
Table 49. China Risperidone Sales (K Pcs) by Type (2016-2021)
Table 50. China Risperidone Sales Share by Type (2016-2021)
Table 51. China Risperidone Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Risperidone Price (USD/Pcs) by Type (2016-2021)
Table 53. China Risperidone Sales (K Pcs) by Type (2022-2027)
Table 54. China Risperidone Sales Share by Type (2022-2027)
Table 55. China Risperidone Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Risperidone Revenue Share by Type (2022-2027)
Table 57. China Risperidone Price (USD/Pcs) by Type (2022-2027)
Table 58. China Risperidone Sales (K Pcs) by Application (2016-2021)
Table 59. China Risperidone Sales Share by Application (2016-2021)
Table 60. China Risperidone Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Risperidone Price (USD/Pcs) by Application (2016-2021)
Table 62. China Risperidone Sales (K Pcs) by Application (2022-2027)
Table 63. China Risperidone Sales Share by Application (2022-2027)
Table 64. China Risperidone Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Risperidone Revenue Share by Application (2022-2027)
Table 66. China Risperidone Price (USD/Pcs) by Application (2022-2027)
Table 67. North America Risperidone Sales by Country (2016-2021) & (K Pcs)
Table 68. North America Risperidone Sales Market Share by Country (2016-2021)
Table 69. North America Risperidone Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Risperidone Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Risperidone Sales by Region (2016-2021) & (K Pcs)
Table 72. Asia Pacific Risperidone Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Risperidone Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Risperidone Revenue Market Share by Region (2016-2021)
Table 75. Europe Risperidone Sales by Country (2016-2021) & (K Pcs)
Table 76. Europe Risperidone Sales Market Share by Country (2016-2021)
Table 77. Europe Risperidone Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Risperidone Revenue Market Share by Country (2016-2021)
Table 79. Latin America Risperidone Sales by Country (2016-2021) & (K Pcs)
Table 80. Latin America Risperidone Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Risperidone Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Risperidone Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Risperidone Sales by Country (2016-2021) & (K Pcs)
Table 84. Middle East and Africa Risperidone Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Risperidone Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Risperidone Revenue Market Share by Country (2016-2021)
Table 87. Janssen Pharmaceutica Corporation Information
Table 88. Janssen Pharmaceutica Description and Business Overview
Table 89. Janssen Pharmaceutica Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 90. Janssen Pharmaceutica Risperidone Product
Table 91. Janssen Pharmaceutica Recent Development
Table 92. Teva Corporation Information
Table 93. Teva Description and Business Overview
Table 94. Teva Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 95. Teva Product
Table 96. Teva Recent Development
Table 97. Sun Pharmaceutical Corporation Information
Table 98. Sun Pharmaceutical Description and Business Overview
Table 99. Sun Pharmaceutical Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 100. Sun Pharmaceutical Product
Table 101. Sun Pharmaceutical Recent Development
Table 102. Aurobindo Corporation Information
Table 103. Aurobindo Description and Business Overview
Table 104. Aurobindo Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 105. Aurobindo Product
Table 106. Aurobindo Recent Development
Table 107. Cipla Corporation Information
Table 108. Cipla Description and Business Overview
Table 109. Cipla Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 110. Cipla Product
Table 111. Cipla Recent Development
Table 112. Invent Farma Group Corporation Information
Table 113. Invent Farma Group Description and Business Overview
Table 114. Invent Farma Group Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 115. Invent Farma Group Product
Table 116. Invent Farma Group Recent Development
Table 117. Medichem Corporation Information
Table 118. Medichem Description and Business Overview
Table 119. Medichem Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 120. Medichem Product
Table 121. Medichem Recent Development
Table 122. Interquim Corporation Information
Table 123. Interquim Description and Business Overview
Table 124. Interquim Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 125. Interquim Product
Table 126. Interquim Recent Development
Table 127. IPCA Corporation Information
Table 128. IPCA Description and Business Overview
Table 129. IPCA Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 130. IPCA Product
Table 131. IPCA Recent Development
Table 132. RPG Corporation Information
Table 133. RPG Description and Business Overview
Table 134. RPG Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 135. RPG Product
Table 136. RPG Recent Development
Table 137. Sharon Corporation Information
Table 138. Sharon Description and Business Overview
Table 139. Sharon Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 140. Sharon Product
Table 141. Sharon Recent Development
Table 142. Torrent Pharmaceuticals Corporation Information
Table 143. Torrent Pharmaceuticals Description and Business Overview
Table 144. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 145. Torrent Pharmaceuticals Product
Table 146. Torrent Pharmaceuticals Recent Development
Table 147. Temad Corporation Information
Table 148. Temad Description and Business Overview
Table 149. Temad Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 150. Temad Product
Table 151. Temad Recent Development
Table 152. Wuxi Jida Corporation Information
Table 153. Wuxi Jida Description and Business Overview
Table 154. Wuxi Jida Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 155. Wuxi Jida Product
Table 156. Wuxi Jida Recent Development
Table 157. Changzhou Siyao Pharmaceuticals Corporation Information
Table 158. Changzhou Siyao Pharmaceuticals Description and Business Overview
Table 159. Changzhou Siyao Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 160. Changzhou Siyao Pharmaceuticals Product
Table 161. Changzhou Siyao Pharmaceuticals Recent Development
Table 162. Ningbo Team Pharm Corporation Information
Table 163. Ningbo Team Pharm Description and Business Overview
Table 164. Ningbo Team Pharm Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 165. Ningbo Team Pharm Product
Table 166. Ningbo Team Pharm Recent Development
Table 167. Zhejiang Huahai Pharmaceutical Corporation Information
Table 168. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 169. Zhejiang Huahai Pharmaceutical Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 170. Zhejiang Huahai Pharmaceutical Product
Table 171. Zhejiang Huahai Pharmaceutical Recent Development
Table 172. TIPR Corporation Information
Table 173. TIPR Description and Business Overview
Table 174. TIPR Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 175. TIPR Product
Table 176. TIPR Recent Development
Table 177. Qilu Pharmaceutical Corporation Information
Table 178. Qilu Pharmaceutical Description and Business Overview
Table 179. Qilu Pharmaceutical Risperidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 180. Qilu Pharmaceutical Product
Table 181. Qilu Pharmaceutical Recent Development
Table 182. Risperidone Market Trends
Table 183. Risperidone Market Drivers
Table 184. Risperidone Market Challenges
Table 185. Risperidone Market Restraints
Table 186. Risperidone Customers List
Table 187. Risperidone Distributors List
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Risperidone Product Picture
Figure 2. Global Risperidone Sales Market Share by Type in 2020 & 2027
Figure 3. Oral Product Picture
Figure 4. Injectable Product Picture
Figure 5. Global Risperidone Sales Market Share by Application in 2020 & 2027
Figure 6. Schizophrenia
Figure 7. Bipolar Disorder
Figure 8. Risperidone Report Years Considered
Figure 9. Global Risperidone Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Risperidone Market Size 2016-2027 (US$ Million)
Figure 11. Global Risperidone Sales 2016-2027 (K Pcs)
Figure 12. Global Risperidone Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Risperidone Sales Market Share by Region (2016-2021)
Figure 14. Global Risperidone Sales Market Share by Region in 2020
Figure 15. Global Risperidone Revenue Market Share by Region (2016-2021)
Figure 16. Global Risperidone Revenue Market Share by Region in 2020
Figure 17. Global Risperidone Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Risperidone Revenue in 2020
Figure 19. Risperidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Risperidone Sales Market Share by Type (2016-2021)
Figure 21. Global Risperidone Sales Market Share by Type in 2020
Figure 22. Global Risperidone Revenue Market Share by Type (2016-2021)
Figure 23. Global Risperidone Revenue Market Share by Type in 2020
Figure 24. Global Risperidone Sales Market Share by Application (2016-2021)
Figure 25. Global Risperidone Sales Market Share by Application in 2020
Figure 26. Global Risperidone Revenue Market Share by Application (2016-2021)
Figure 27. Global Risperidone Revenue Market Share by Application in 2020
Figure 28. China Risperidone Sales Growth Rate 2016-2027 (K Pcs)
Figure 29. China Risperidone Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Risperidone Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Risperidone Players Market Share by Revenue in Risperidone in 2020
Figure 32. China Risperidone Revenue Share by Type (2016-2021)
Figure 33. China Risperidone Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Risperidone Revenue Share by Application (2016-2021)
Figure 35. China Risperidone Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Risperidone Sales Growth Rate 2016-2021 (K Pcs)
Figure 37. North America Risperidone Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Risperidone Sales Market Share by Country in 2020
Figure 39. North America Risperidone Revenue Market Share by Country in 2020
Figure 40. U.S. Risperidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 41. U.S. Risperidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Risperidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 43. Canada Risperidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Risperidone Sales Growth Rate 2016-2021 (K Pcs)
Figure 45. Europe Risperidone Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Risperidone Sales Market Share by Country in 2020
Figure 47. Europe Risperidone Revenue Market Share by Country in 2020
Figure 48. Germany Risperidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 49. Germany Risperidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Risperidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 51. France Risperidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Risperidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 53. U.K. Risperidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Risperidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 55. Italy Risperidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Risperidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 57. Russia Risperidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Risperidone Sales Growth Rate 2016-2021 (K Pcs)
Figure 59. Asia Pacific Risperidone Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Risperidone Sales Market Share by Region in 2020
Figure 61. Asia Pacific Risperidone Revenue Market Share by Region in 2020
Figure 62. China Risperidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 63. China Risperidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Risperidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 65. Japan Risperidone Revenue Gr
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs